Healthcare Business - Page 2

Merrimack Discontinues Cancer Study Amidst Layoffs

Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) has announced that it will be discontinuing one of its cancer drugs, as well as conducting layoffs. Specifically, the firm is discontinuing MM-310 for the ...
Read Full Story »

PTSD Treatment Looked at for Fibromyalgia

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares jumped on Monday after the firm announced the expansion of its late-stage post-traumatic stress disorder (PTSD) treatment. Specifically, the firm announced the expansion ...
Read Full Story »

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

Biopharmaceutical company Aptinyx Inc. (NASDAQ: APTX) has announced positive preclinical data on its novel NMDA receptor modulator, NYX-458, demonstrating reversal of cognitive deficits in a nonhuman primate model of ...
Read Full Story »

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Agricultural engineering company Evogene Ltd. (NASDAQ: EVGN) has announced the establishment of a new subsidiary, called Canonic, to develop next-generation medical cannabis products. Keep in mind that while Evogene may ...
Read Full Story »

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

Between 2006 and 2017, U.S. retail pharmacies filled 233.7 million prescriptions for opioids. In 2006, opioid prescriptions in 14 states met or exceeded a medically determined high dosage level. That ...
Read Full Story »

What’s Next for Sangamo After This Hemophilia Study

Sangamo Therapeutics Inc. (NASDAQ: SGMO) shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer Inc. (NYSE: PFE). The Phase 1/2 ...
Read Full Story »

How Apyx Medical Was Crushed by the FDA

Apyx Medical Corp. (NASDAQ: APYX) shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of J-Plasma/Renuvion for ...
Read Full Story »

What’s Next for Tricida’s Chronic Kidney Disease Treatment

After Tricida Inc. (NASDAQ: TCDA) announced results from its chronic kidney disease (CKD) trial, its shares jumped on Thursday. Specifically, the results come from TRCA-301 (veverimer), in 196 CKD patients ...
Read Full Story »

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

Proteon Therapeutics Inc. (NASDAQ: PRTO) shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with chronic kidney disease (CKD). Specifically, the Phase ...
Read Full Story »

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Shares of drug giant Pfizer Inc. (NYSE: PFE) have lagged rival Merck & Co. Inc. (NYSE: PFE). The gain of 23% for Pfizer from this time a year ago is ...
Read Full Story »

Why the Market Is Punishing Centene Over Its Planned WellCare Health Plans Acquisition

Investors frequently win when they invest in a company that is being acquired, and sometimes they even get a bump in owning shares of the company acquisition. And some mergers ...
Read Full Story »

What’s Next for Axsome Therapeutics After This FDA Approval

Axsome Therapeutics Inc. (NASDAQ: AXSM) shares jumped on Wednesday after the firm said it received an update from the U.S. Food and Drug Administration (FDA). Essentially, the agency granted Breakthrough ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, March 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Will Pacemakers and Other Medical Implants Be Hacked?

Last October, the U.S. Food and Drug Administration (FDA) issued a call for comments to new guidance from the agency on the cybersecurity vulnerabilities of networked medical devices that can ...
Read Full Story »